Abstract:Objective To detect the expression of peripheral blood free prostate specific antigen (fSPA),total prostate specific antigen (tSPA),prostate specific antigen density (PSAD) and prostate cancer gene 3 (PCA3) in prostate disease,and the significance of combined detection of fSPA,tSPA and PCA3.Methods 67 patients with prostate cancer,75 patients with prostatic hyperplasia and 70 healthy male were selected as the research objects from Dec.2014 to Jul.2016.The serum level of fSPA and tSPA was detected by chemiluminescence immune staining method.The prostate volume was tested by ultrasonic sound and PSAD value was calculated.The total RNA was extracted by Trizol,and the serum PCA3 mRNA expression was detected by RT-PCR.The specificity and sensitivity of combined detection of fSPA,tSPA and PCA3 were analyzed.Results The serum levels of fSPA,tSPA,PSAD and PCA3 in prostate cancer were significantly higher than those in patients with prostatic hyperplasia and healthy male,and they were higher in patients with hyperplasia of prostate than in healthy male,and the differences had statistical significance (P＜0.01).The serum levels of fSPA,tSPA,PSAD and PCA3 were higher in patients with Gleason score ≥7 points and in T3-T4 stage than in patients with Gleason score ＜7 and in T1-T2 stage,and the difference had statistical significance (P＜0.01).The serum levels of fSPA,tSPA,PSAD and PCA3 were positively correlated with Gleason score and TMN pathological stage,and the difference had statistical significance (P＜0.01).The AUC value of fSPA,tSPA,PSAD and PCA3 in diagnosis of prostate cancer was 0.53,0.57,0.63 and 0.75,and the AUC value of combined detection was 0.92.The combined detection efficiency was higher than the single index.The specificity of fSPA,tSPA,PSAD and PCA3 was 67.16％,68.66％,73.13％ and 85.07％,and the sensitivity was 71.64％,70.15％,74.63％ and 82.09％ respectively.The specificity of combined detection was 97.01％,the sensitivity was 92.54％,and the difference had statistical significance (P＜0.01).Conclusion The serum level of fSPA,tSPA,PSAD and PCA3 is increased in prostate disease,and is negatively correlated with Gleason score and TMN pathological stage.The combined detection of fSPA,tSPA,PSAD and PCA3 can improve the sensitivity and specificity of prostate disease diagnosis,and is of high clinical value.

Relationship of the age and serum PSA in patients with prostate adenocarcinoma: a preliminary analysis

The effect of patients′ age and prostatic volume on serum prostate specific antigen (PSA) level

Variation of serum PSA with age in benign prostatic hyperplasia patients

Applied Research of Prostate Specific Antigen Combined with Prostate Cancer Gene 3 in Diagnosis of Prostate Disease

Age of prostate specific antigen 4 ～ 10 mu g/L patient's cancer detection and research on the effects of illness

The predictive value of serum PSA to Gleason score in patients with prostate adenocarcinoma

[Age Correlates with Gleason Score in Patients with Prostate Adenocarcinoma].

[Relationship of age over 50 years and serum prostate specific antigen in men of Beijing multicentre communities].

Study on the relationship between age,prostate volume and prostate specific antigen of patients with benign prostatic hyperplasia

The Age-specific Distribution of T-PSA in Benign Prostatic Hyperplasia Patients of Shanghai

Age-Specific Cutoff Value for the Application of Percent Free Prostate-Specific Antigen (PSA) in Chinese Men with Serum PSA Levels of 4.0-10.0 Ng/ml.

Analysis of Age-Specific Prostate Specific Antigen and Related Parameters in 22 055 Elderly Men

A relation analysis between age and PSA about the serum prostate specific antigen in the benign prostatic hyperplasia patients who had received operation

Relationship between prostatic specific antigen and clinical symptomatic parameters in benign prostatic hyperplasia with lower urinary tract symptoms

Values For Free/Total Prostate-Specific Antigen Ratio As A Function Of Age: Necessity Of Reference Validation In A Turkish Population

Clinical significance of serum TPSA,FPSA/TPSA and PSAD in diagnosis of prostate carcinoma

Clinical Application of Free/total PSA Ratio in the Diagnosis of Prostate Cancer in Men over 50 Years of Age with Total PSA Levels of 2.0–25.0 Ng Ml-1 in Western China

[Analysis of reference range responsible to normal percent value of free prostate specific antigen from men without prostate disease].

[Measurement and Analysis of Different Serum PSA in Patients with Benign Prostatic Hyperplasia].

[Age-specific reference ranges for serum prostate-specific antigen in Chinese men].

Changes and clinilcal significances of serum total prostate-specific antigen,free prostate-specific antigen and free/total prostate-specific antigen in patients with benign and malignant prostatic diseases